021-51111890
购物车（）
sales@molnova.cn
CU-115
CAS No. 2471982-20-2
CU-115 ( N-(4-(3,5-bis(trifluoromethyl)phenoxy)phenyl)-2-fluoro-6-iodobenzamide )
产品货号. M28821 CAS No. 2471982-20-2
CU-115 是 TLR8 的选择性拮抗剂，对 TLR8 和 TLR7 的 IC50 分别为 1.04 μM 和 >50 μM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1416 | 有现货 |
|
| 10MG | ￥2261 | 有现货 |
|
| 25MG | ￥3841 | 有现货 |
|
| 50MG | ￥5375 | 有现货 |
|
| 100MG | ￥7137 | 有现货 |
|
| 500MG | ￥14490 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥1767 | 有现货 |
|
生物学信息
-
产品名称CU-115
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述CU-115 是 TLR8 的选择性拮抗剂，对 TLR8 和 TLR7 的 IC50 分别为 1.04 μM 和 >50 μM。
-
产品描述CU-115 is a selective antagonist of TLR8 with IC50s of 1.04 μM and >50 μM for TLR8 and TLR7, respectively.(In Vitro):CU-115 (1, 5, and 20 μM) inhibits TLR9 to 10-25% inhibition. CU-115 (5-20 μM) inhibits increases in the activity of type I IFN transcriptional induced by the ssRNA nucleic acid ligands 3p-hpRNA or G3-YSD. CU-115 (5-20 μM) abolishes the TNF-α production activated by R848 (1 μg/ml) and represses the expression of IL-1β in hTHP-1 cells. CU-115 does not modulate the NF-kB inhibition induced by Pam2CSK4, Pam3CSK4, LPS, R848, Poly(I:C), and Flic in HEK-293 TLR1/2, TLR2/6, TLR3, and TLR4 cells.
-
体外实验In endosomal and non-endosomal TLR specificity studies, Human embryonic kidney (HEK) 293 cells expressing human tolllike receptor (hTLR) gene and an inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were incubated with CU-115 for 16 hours. As a result, CU-115 displays activity for TLR7 and TLR8 at low concentrations (0.5 μM).CU-115 does not modulate the NF-kB inhibition induced by Pam2CSK4, Pam3CSK4, Poly(I:C), LPS, R848, and Flic in HEK-293 TLR1/2, TLR2/6, TLR3, and TLR4 cells. And CU-115 inhibits TLR9 signaling at 1, 5, and 20 μM and ~10-25% inhibition.CU-115 (5-20 μM) inhibits increases in type I IFN transcriptional activity induced by the ssRNA nucleic acid ligands 3p-hpRNA or G3-YSD in a luciferase reporter assay.CU-115 (0.5, 1.0, 5, and 20 μM; 16 hours) is nontoxic at low concentrations (0.5 and 20 μM) and toxic at 100 μM in Hek293 TLR7 and TLR8 cells. CU-115 also is nontoxic at low concentrations (0.5 and 20 μM) and displays partial toxicity at 100 μM in THP Dual cells.The enzyme-linked immunosorbent assay (ELISA) is performed to measure upregulation/inhibition of TNF-α in human THP-1 cells (hTHP-1). CU-115 (5-20 μM)abolishes the TNF-α production activated by R848 (1 μg/ml) in hTHP1. It also represses the expression of IL-1β in hTHP-1 cells. These results suggest that CU-115 suppresses TLR8 and TLR7 signaling pathways.
-
体内实验——
-
同义词N-(4-(3,5-bis(trifluoromethyl)phenoxy)phenyl)-2-fluoro-6-iodobenzamide
-
通路Immunology/Inflammation
-
靶点TLR
-
受体ABHD6
-
研究领域——
-
适应症——
化学信息
-
CAS Number2471982-20-2
-
分子量569.21
-
分子式C21H11F7INO2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (175.68 mM)
-
SMILESO=C(NC1=CC=C(OC=2C=C(C=C(C2)C(F)(F)F)C(F)(F)F)C=C1)C=3C(F)=CC=CC3I
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Daniel A Bachovchin, et al. Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening. Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):20941-6.
产品手册
关联产品
-
Tomaralimab
Tomaralimab (OPN-305) 是一种人源化的抗-TLR2 (anti-TLR2) IgG4 单克隆抗体。Tomaralimab 具有研究骨髓增生异常综合征 (MDS) 的潜力。
-
TLR7 agonist 3
TLR7 agonist 3 (Compound 2) 是一种有效的 Toll 样受体 7 (TLR7) 激动剂。 TLR7 在免疫激活过程中具有重要作用，可用于开发免疫调节剂。
-
Poly(I:C)
Poly (I:C) 是一种合成的双链 RNA (dsRNA) 类似物，是一种免疫刺激剂，可作为最有效的干扰素 (IFN) 诱导剂。它也是一种 Toll 样受体 3 (TLR3) 激动剂。包含 TLR7/8 激动剂 R848 或 CL075 的混合物与聚 (I:C) 结合可产生 3-d 成熟树突状细胞。
